We are live on ! Find out more
OPGN

OpGen, Inc

Delisted

OPGN was delisted on the 19th of August, 2024.

26 hedge funds and large institutions have $522K invested in OpGen, Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

13% more funds holding

Funds holding: 2326 (+3)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

79% less capital invested

Capital invested by funds: $2.52M → $522K (-$1.99M)

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
3
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change

OPGN Hedge Fund Activity: Q4 2022 in Review

26 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in OpGen, Inc (OPGN) for Q4 2022, worth a combined $522K — down 79% from $2.52M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OPGN positions and 5 closed out — a net gain of 3 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $35.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.52M sold.

  • 26 institutional investors held OpGen, Inc (OPGN) as of Q4 2022, up from 23 in Q3 2022.
  • Funds reported $522K of OpGen, Inc stock for Q4 2022, down 79% quarter-over-quarter.
  • 8 funds opened new OpGen, Inc positions in Q4 2022 and 5 closed out, a net change of +3 holders.
  • The largest OpGen, Inc buyer in Q4 2022 was HRT Financial, an estimated $35.2K added.
  • The largest OpGen, Inc seller in Q4 2022 was Armistice Capital, an estimated $1.52M sold.

Based on aggregated 13F filings for Q4 2022.